Amphastar Pharmaceuticals (NASDAQ:AMPH – Get Free Report) and UroGen Pharma (NASDAQ:URGN – Get Free Report) are both medical companies, but which is the superior business? We will contrast the two ...

Exenatide is a GLP-1 agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults with Type 2 diabetes mellitus.

Intranasal (IN) delivery of medications is ... topical anesthetics, glucagon for hypoglycemia, and agents for epistaxis control. Many new medications, or new uses for common medications via ...

It offers BAQSIMI, a nasal spray for the treatment of severe hypoglycemia ... REXTOVY and Naloxone for opioid overdose; Glucagon for injection emergency kit; and Cortrosyn, for use as a diagnostic ...

Glucagon is a recognised therapy for the disorder ... 2019 as a hypoglycaemia rescue therapy for diabetics. Eli Lilly's nasal spray Baqsimi was also approved in 2019 for a similar indication.

Pontiac General Hospital files for Chapter 11 bankruptcy; health systems are hiring doctors from PE-backed firms; and more.

Objective—Glucagon-like peptide 1 (GLP-1) exerts beneficial antidiabetic actions via effects on pancreatic β- and α-cells. Previous studies have focused on the improvements in β-cell function ...

The annual meeting of the American Heart Association was held this year from Nov. 16 to 18 in Chicago, drawing attendees from ...

Nasal Spray Version of Common Diuretic Has Potential to Help Treat Heart Failure Nov. 18, 2024 — A study testing a new nasal spray form of the medication bumetanide, a commonly prescribed ...

After hours: November 27 at 6:33 PM EST Loading Chart for AMPH ...